Home/Tag: eRegulatory
29 07, 2019

Overcoming Four Common Challenges in Multicenter Research


Efficiently managing multicenter clinical trials is an essential capability of the modern research center. Complex protocols often require diverse subjects spread across a vast network of research sites - increasing pressure on the coordinating center to streamline operations, maintain oversight, and avoid compliance risks. While the challenges of managing multicenter trials is unique for [...]

Overcoming Four Common Challenges in Multicenter Research2019-08-01T13:38:11-04:00
20 06, 2019

Pioneering New Methods of Remote Monitoring in Clinical Trials


June 20, 2019, Atlanta, GA: Today Florence announced assignment of U.S. Patent No. 10,319,479 by the United States Patent and Trademark Office for: “Remote Monitoring and Dynamic Document Management Systems and Methods.” This patent covers how Florence’s applications process essential clinical trial documents—enabling a new approach to remote monitoring for Pharmaceutical companies, Medical Device [...]

Pioneering New Methods of Remote Monitoring in Clinical Trials2019-08-02T11:40:12-04:00
19 02, 2019

Florence and SignalPath Announce Strategic Partnership


ORLANDO, Fla., Feb. 19, 2019 /PRNewswire/ -- At the Summit for Clinical Ops Executives (SCOPE), Florence and SignalPath announced a strategic partnership to optimize clinical research operations through the integration of their industry leading offerings. The partnership allows for a seamless experience for mutual customers of SignalPath's clinical trial management system (CTMS) and Florence's regulatory document management software (eRegulatory). The [...]

Florence and SignalPath Announce Strategic Partnership2019-09-06T20:24:13-04:00
12 02, 2019

5 Key Advantages of eRegulatory


Over 75% of clinical trial sites who have not yet adopted eRegulatory plan to do so in 2019. Why? In addition to growing industry pressure from sponsors who expect a digital site infrastructure, trial sites with eRegulatory platforms are introducing key advantages over those sites without eReg. What are those advantages? Download Five Key Benefits [...]

5 Key Advantages of eRegulatory2019-08-02T15:45:49-04:00
18 01, 2019

How Lauren Begnaud Transitioned 65 Sites to eRegulatory at US Oncology


In this interview, we talked with Lauren Begnaud, Manager of Regulatory Affairs at the US Oncology Network, to discover how she successfully migrated 65 trial sites, 400 studies, and 2,000 Investigators and Support Staff to Florence eBinders for eRegulatory. Lauren has over 10 years of experience in the clinical research field and has successfully [...]

How Lauren Begnaud Transitioned 65 Sites to eRegulatory at US Oncology2019-08-01T17:09:06-04:00
7 08, 2018

Ten Must-Have Capabilities When Evaluating eRegulatory Platforms


Successfully transitioning your team to an eRegulatory solution, while avoiding costly compliance mistakes and realizing true time-saving benefits, requires careful evaluation of potential platforms. After helping thousands of research teams implement eRegulatory, our team has put together these ten essential capabilities to look for when evaluating solutions. You can download our full Guide to Selecting [...]

Ten Must-Have Capabilities When Evaluating eRegulatory Platforms2020-03-03T13:29:55-05:00
14 06, 2018

Webinar | Avoiding Digital Site Surprises


Recorded Webinar: Avoiding Digital Site Surprises Odds are that your CRA team is already logging into electronic investigator site files at some of your sites. Now what? View this on-demand webinar to learn how leading sponsors and CROs are taking advantage of digital platforms at trial sites. We explore the how your [...]

Webinar | Avoiding Digital Site Surprises2019-08-02T15:56:28-04:00
13 06, 2018

How to Avoid the Top 5 Clinical Trial FDA Inspection Failures


Your heart begins beating faster and sweat begins forming on your forehead - the FDA is calling. Many things can trigger an FDA inspection - most falling into routine study-related visits, while some are "for cause," stemming from complaints or sponsor concerns. Sites that have a new drug application will most likely experience an FDA inspection. [...]

How to Avoid the Top 5 Clinical Trial FDA Inspection Failures2020-03-11T16:19:49-04:00